Cite
HARVARD Citation
Lee, C. et al. (n.d.). 19PPreclinical drug testing and clinical trial planning of palbociclib (CDK4/6 inhibitor) drug combination with a PI3K or MAPK inhibitor for colorectal cancer (CRC). Annals of oncology. p. . [Online].